ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,286 | -6.3% | 145,473 | +1.9% | 0.00% | – |
| Q2 2023 | $229,864 | +53732.3% | 142,773 | -3.1% | 0.00% | -100.0% |
| Q1 2023 | $427 | -9.0% | 147,372 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $469 | -99.9% | 143,057 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $536,000 | -50.6% | 141,705 | +1.8% | 0.00% | -50.0% |
| Q2 2022 | $1,084,000 | -2.3% | 139,185 | +16.6% | 0.00% | +100.0% |
| Q1 2022 | $1,109,000 | -45.1% | 119,354 | -6.8% | 0.00% | -50.0% |
| Q4 2021 | $2,019,000 | -10.5% | 128,089 | +1.6% | 0.00% | -33.3% |
| Q3 2021 | $2,256,000 | +14.2% | 126,037 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,975,000 | +18.4% | 127,034 | +9.4% | 0.00% | +50.0% |
| Q1 2021 | $1,668,000 | -30.7% | 116,133 | -5.2% | 0.00% | -33.3% |
| Q4 2020 | $2,406,000 | +73.2% | 122,545 | +14.4% | 0.00% | +50.0% |
| Q3 2020 | $1,389,000 | -10.2% | 107,164 | +1.0% | 0.00% | -33.3% |
| Q2 2020 | $1,546,000 | +146.2% | 106,115 | +43.9% | 0.00% | +200.0% |
| Q1 2020 | $628,000 | -45.3% | 73,762 | +5.8% | 0.00% | -50.0% |
| Q4 2019 | $1,148,000 | +19.5% | 69,716 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $961,000 | -22.6% | 68,067 | +10.3% | 0.00% | 0.0% |
| Q2 2019 | $1,241,000 | -43.4% | 61,735 | +11.8% | 0.00% | -50.0% |
| Q1 2019 | $2,194,000 | +12.2% | 55,195 | -2.0% | 0.00% | 0.0% |
| Q4 2018 | $1,956,000 | +27.0% | 56,305 | +51.2% | 0.00% | +33.3% |
| Q3 2018 | $1,540,000 | +6.8% | 37,243 | -5.1% | 0.00% | 0.0% |
| Q2 2018 | $1,442,000 | +10.2% | 39,238 | +16.9% | 0.00% | 0.0% |
| Q1 2018 | $1,309,000 | +166.1% | 33,565 | +23.4% | 0.00% | +200.0% |
| Q4 2017 | $492,000 | -5.9% | 27,202 | -13.9% | 0.00% | 0.0% |
| Q3 2017 | $523,000 | +19.1% | 31,598 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $439,000 | -24.2% | 31,373 | +11.3% | 0.00% | 0.0% |
| Q1 2017 | $579,000 | +49.2% | 28,198 | +3.1% | 0.00% | 0.0% |
| Q4 2016 | $388,000 | -34.5% | 27,350 | -1.1% | 0.00% | -50.0% |
| Q3 2016 | $592,000 | -1.3% | 27,655 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $600,000 | +82.4% | 26,645 | +53.9% | 0.00% | +100.0% |
| Q1 2016 | $329,000 | -28.3% | 17,310 | -0.3% | 0.00% | 0.0% |
| Q4 2015 | $459,000 | +4.1% | 17,370 | +23.9% | 0.00% | -50.0% |
| Q3 2015 | $441,000 | -32.6% | 14,025 | +13.1% | 0.00% | 0.0% |
| Q2 2015 | $654,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |